November 2014

Triple Therapy for Hepatitis C Infection: Bacterial Infection Risk Rises, Changes

December 01, 2014

Articles

Patients who have HCV infection are at high risk for arthralgia, myalgias, pruritus, neuropathy, and decompensated livers. Until recently the sole available treatment was interferon. After the US Food and Drug Administration (FDA) approved ribavirin, patients who took ribavirin plus interferon responded better. Now, the FDA has approved a small selection of oral antivirals to treat hepatitis C.

DNA Sequencing Could Lead to More Accurate Pneumonia Diagnosis

December 01, 2014

Articles

A team of researchers at George Washington University has reported that next-generation sequencing of sputum samples taken from patients in the intensive care unit can accurately identify the strain of ventilator-associated pneumonia a patient is infected with.

Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B

December 01, 2014

Articles

Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.

Age-related Diseases Don't Occur Earlier in HIV-infected Patients

December 01, 2014

Articles

Despite previous research suggesting HIV patients have an increased likelihood of suffering from a heart attack, kidney failure, or cancer, Johns Hopkins Bloomberg School of Public Health investigators showed the age they encounter these conditions were similar to their uninfected counterparts.

x